Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Vries, I. J. M.
Right arrow Articles by Figdor, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Vries, I. J. M.
Right arrow Articles by Figdor, C. G.
[Cancer Research 63, 12-17, January 2003]
© 2003 American Association for Cancer Research

Advances in Brief

Effective Migration of Antigen-pulsed Dendritic Cells to Lymph Nodes in Melanoma Patients Is Determined by Their Maturation State1 ,2

I. Jolanda M. de Vries3, Daniëlle J. E. B. Krooshoop3, Nicole M. Scharenborg, W. Joost Lesterhuis, J. Heleen S. Diepstra, Goos N. P. van Muijen, Simon P. Strijk, Theo J. Ruers, Otto C. Boerman, Wim J. G. Oyen, Gosse J. Adema, Cornelis J. A. Punt and Carl G. Figdor4

Departments of Tumor Immunology [I. J. M. d. V., D. J. E. B. K., N. M. S., G. J. A., C. G. F.], Medical Oncology [W. J. L., C. J. A. P.], Pathology [J. H. S. D., G. N. P. v. M.], Radiology [S. P. S.], Surgery [T. J. R.], and Nuclear Medicine [O. C. B., W. J. G. O.], University Medical Center Nijmegen, 6500 HB Nijmegen, the Netherlands

Dendritic cells are the professional antigen-presenting cells of the immune system. To induce an effective immune response, these cells should not only express high levels of MHC and costimulatory molecules but also migrate into the lymph nodes to interact with naïve T cells. Here, we demonstrate that in vitro-generated mature, but not immature dendritic cells, efficiently migrate into the T-cell areas of lymph nodes of melanoma patients. This difference is confirmed by in vitro studies, in which immature dendritic cells are strongly adherent, whereas mature dendritic cells remain highly motile. Our present findings demonstrate that the ability of dendritic cells to mount a proper immune response correlates with their ability to migrate both in vitro and in vivo.




This article has been cited by other articles:


Home page
 FASEB J.Home page
B. Mattioli, E. Straface, P. Matarrese, M. G. Quaranta, L. Giordani, W. Malorni, and M. Viora
Leptin as an immunological adjuvant: enhanced migratory and CD8+ T cell stimulatory capacity of human dendritic cells exposed to leptin
FASEB J, June 1, 2008; 22(6): 2012 - 2022.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Jasny, M. Eisenblatter, K. Matz-Rensing, K. Tenner-Racz, M. Tenbusch, A. Schrod, C. Stahl-Hennig, V. Moos, T. Schneider, P. Racz, et al.
IL-12-Impaired and IL-12-Secreting Dendritic Cells Produce IL-23 upon CD154 Restimulation
J. Immunol., May 15, 2008; 180(10): 6629 - 6639.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
S. F. G. van Helden, M. M. Oud, B. Joosten, N. Peterse, C. G. Figdor, and F. N. van Leeuwen
PGE2-mediated podosome loss in dendritic cells is dependent on actomyosin contraction downstream of the RhoA-Rho-kinase axis
J. Cell Sci., April 1, 2008; 121(7): 1096 - 1106.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Lapteva, M. R. Seethammagari, B. A. Hanks, J. Jiang, J. M. Levitt, K. M. Slawin, and D. M. Spencer
Enhanced Activation of Human Dendritic Cells by Inducible CD40 and Toll-like Receptor-4 Ligation
Cancer Res., November 1, 2007; 67(21): 10528 - 10537.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
O. Adotevi, B. Vingert, L. Freyburger, P. Shrikant, Y.-C. Lone, F. Quintin-Colonna, N. Haicheur, M. Amessou, A. Herbelin, P. Langlade-Demoyen, et al.
B Subunit of Shiga Toxin-Based Vaccines Synergize with {alpha}-Galactosylceramide to Break Tolerance against Self Antigen and Elicit Antiviral Immunity
J. Immunol., September 1, 2007; 179(5): 3371 - 3379.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Holtkamp, S. Kreiter, A. Selmi, P. Simon, M. Koslowski, C. Huber, O. Tureci, and U. Sahin
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
Blood, December 15, 2006; 108(13): 4009 - 4017.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Yagi, H. Hashizume, T. Horibe, Y. Yoshinari, M. Hata, A. Ohshima, T. Ito, M. Takigawa, A. Shibaki, H. Shimizu, et al.
Induction of therapeutically relevant cytotoxic T lymphocytes in humans by percutaneous Peptide immunization.
Cancer Res., October 15, 2006; 66(20): 10136 - 10144.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. F. G. van Helden, D. J. E. B. Krooshoop, K. C. M. Broers, R. A. P. Raymakers, C. G. Figdor, and F. N. van Leeuwen
A Critical Role for Prostaglandin E2 in Podosome Dissolution and Induction of High-Speed Migration during Dendritic Cell Maturation
J. Immunol., August 1, 2006; 177(3): 1567 - 1574.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. H.M.G.M. den Brok, R. P.M. Sutmuller, S. Nierkens, E. J. Bennink, L. W.J. Toonen, C. G. Figdor, T. J.M. Ruers, and G. J. Adema
Synergy between In situ Cryoablation and TLR9 Stimulation Results in a Highly Effective In vivo Dendritic Cell Vaccine.
Cancer Res., July 15, 2006; 66(14): 7285 - 7292.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. J.C.L.M. Vuylsteke, B. G. Molenkamp, P. A.M. van Leeuwen, S. Meijer, P. G.J.T.B. Wijnands, J. B.A.G. Haanen, R. J. Scheper, and T. D. de Gruijl
Tumor-Specific CD8+ T Cell Reactivity in the Sentinel Lymph Node of GM-CSF-Treated Stage I Melanoma Patients is Associated with High Myeloid Dendritic Cell Content.
Clin. Cancer Res., May 1, 2006; 12(9): 2826 - 2833.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
D. Schadendorf, S. Ugurel, B. Schuler-Thurner, F. O. Nestle, A. Enk, E.-B. Brocker, S. Grabbe, W. Rittgen, L. Edler, A. Sucker, et al.
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
Ann. Onc., April 1, 2006; 17(4): 563 - 570.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. A. Hokey, A. T. Larregina, G. Erdos, S. C. Watkins, and L. D. Falo Jr.
Tumor Cell Loaded Type-1 Polarized Dendritic Cells Induce Th1-Mediated Tumor Immunity
Cancer Res., November 1, 2005; 65(21): 10059 - 10067.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Morandi, R. Costa, M. Falco, S. Parolini, A. De Maria, G. Ratto, M. C. Mingari, G. Melioli, A. Moretta, and G. Ferlazzo
Distinctive Lack of CD48 Expression in Subsets of Human Dendritic Cells Tunes NK Cell Activation
J. Immunol., September 15, 2005; 175(6): 3690 - 3697.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Mahnke, Y. Qian, S. Fondel, J. Brueck, C. Becker, and A. H. Enk
Targeting of Antigens to Activated Dendritic Cells In vivo Cures Metastatic Melanoma in Mice
Cancer Res., August 1, 2005; 65(15): 7007 - 7012.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Dumortier, G. J. D. van Mierlo, D. Egan, W. van Ewijk, R. E. M. Toes, R. Offringa, and C. J. M. Melief
Antigen Presentation by an Immature Myeloid Dendritic Cell Line Does Not Cause CTL Deletion In Vivo, but Generates CD8+ Central Memory-Like T Cells That Can Be Rescued for Full Effector Function
J. Immunol., July 15, 2005; 175(2): 855 - 863.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
D. Dieckmann, E. S. Schultz, B. Ring, P. Chames, G. Held, H. R. Hoogenboom, and G. Schuler
Optimizing the exogenous antigen loading of monocyte-derived dendritic cells
Int. Immunol., May 1, 2005; 17(5): 621 - 635.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Schnurr, Q. Chen, A. Shin, W. Chen, T. Toy, C. Jenderek, S. Green, L. Miloradovic, D. Drane, I. D. Davis, et al.
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery
Blood, March 15, 2005; 105(6): 2465 - 2472.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
D. A. Caruso, L. M. Orme, A. M. Neale, F. J. Radcliff, G. M. Amor, W. Maixner, P. Downie, T. E. Hassall, M. L.K. Tang, and D. M. Ashley
Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer
Neuro-oncol, July 1, 2004; 6(3): 236 - 246.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
M. H. M. G. M. den Brok, R. P. M. Sutmuller, R. van der Voort, E. J. Bennink, C. G. Figdor, T. J. M. Ruers, and G. J. Adema
In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity
Cancer Res., June 1, 2004; 64(11): 4024 - 4029.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. H. Vonderheide, S. M. Domchek, J. L. Schultze, D. J. George, K. M. Hoar, D.-Y. Chen, K. F. Stephans, K. Masutomi, M. Loda, Z. Xia, et al.
Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes
Clin. Cancer Res., February 1, 2004; 10(3): 828 - 839.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Brown, W. Gao, S. Alber, A. Trichel, M. Murphey-Corb, S. C. Watkins, A. Gambotto, and S. M. Barratt-Boyes
Adenovirus-Transduced Dendritic Cells Injected into Skin or Lymph Node Prime Potent Simian Immunodeficiency Virus-Specific T Cell Immunity in Monkeys
J. Immunol., December 15, 2003; 171(12): 6875 - 6882.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Nair, C. McLaughlin, A. Weizer, Z. Su, D. Boczkowski, J. Dannull, J. Vieweg, and E. Gilboa
Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation
J. Immunol., December 1, 2003; 171(11): 6275 - 6282.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. J. M. de Vries, W. J. Lesterhuis, N. M. Scharenborg, L. P. H. Engelen, D. J. Ruiter, M.-J. P. Gerritsen, S. Croockewit, C. M. Britten, R. Torensma, G. J. Adema, et al.
Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients
Clin. Cancer Res., November 1, 2003; 9(14): 5091 - 5100.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.